Raison Charles L, Lin Jin-Mann S, Reeves William C
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1365C Clifton Road, Room 5004, Atlanta, GA 30322, USA.
Brain Behav Immun. 2009 Mar;23(3):327-37. doi: 10.1016/j.bbi.2008.11.005. Epub 2008 Dec 11.
Alterations in the innate immune response may contribute to the pathogenesis of chronic fatigue syndrome (CFS). However, studies have been limited by small sample sizes, use of patients from tertiary care settings, inappropriate selection of controls, and failure to control for confounding demographic, medical and behavioral factors independently associated with immune activity. It is also not known whether specific symptoms account for observed associations between CFS and the innate immune response. To address these limitations, the current study examined plasma concentrations of high-sensitivity c-reactive protein (hs-CRP), white blood cell count (WBC) and a combined inflammation factor in a large population-based sample. Log-transformed mean plasma concentrations of hs-CRP were increased in subjects with CFS (n=102) and in subjects with unwellness symptoms that did not meet diagnostic criteria for CFS (defined as "insufficient fatigue" [ISF]) (n=240) when compared to subjects who were well (n=115). Log transformed WBC was increased in ISF and was increased at a trend level in CFS. The combined inflammation factor was increased in both CFS and ISF. Subjects with CFS and ISF did not differ on any of the inflammation measures. In the entire subject population, the physical component summary score (PCS), but not the mental component summary score (MCS), from the Medical Outcomes Study Short Form-36 (SF-36) was negatively associated with each of the inflammation measures. Depressive symptoms were also associated with increased log hs-CRP. After adjustment for age, sex, race, location of residence, BMI, depressive status and immune-modulating medications, subjects classified as ISF continued to demonstrate increased log hs-CRP, WBC and elevations on the inflammation factor when compared to well controls; however, associations between CFS and log hs-CRP and the inflammation factor were no longer statistically significant. After adjustment, PCS score also remained independently associated with each of the inflammation measures. These findings support a role for innate immune activation in unexplained fatigue and unwellness, but do not suggest that immune activation is specific to CFS.
先天免疫反应的改变可能促使慢性疲劳综合征(CFS)的发病。然而,此前的研究存在样本量小、使用三级医疗机构患者、对照选择不当以及未能独立控制与免疫活性相关的混杂人口统计学、医学和行为因素等局限性。目前也不清楚特定症状是否能解释CFS与先天免疫反应之间的观察关联。为解决这些局限性,本研究在一个基于人群的大样本中检测了高敏C反应蛋白(hs-CRP)、白细胞计数(WBC)和综合炎症因子的血浆浓度。与健康受试者(n = 115)相比,CFS受试者(n = 102)以及有不适症状但未达到CFS诊断标准(定义为“疲劳不足”[ISF])的受试者(n = 240)中,hs-CRP的对数转换平均血浆浓度升高。ISF受试者的对数转换WBC升高,CFS受试者的WBC呈趋势性升高。CFS和ISF受试者的综合炎症因子均升高。CFS和ISF受试者在任何炎症指标上均无差异。在整个受试者群体中,医学结局研究简表-36(SF-36)中的身体成分汇总得分(PCS)而非精神成分汇总得分(MCS)与各炎症指标呈负相关。抑郁症状也与hs-CRP对数升高有关。在调整年龄、性别、种族、居住地点、BMI、抑郁状态和免疫调节药物后,与健康对照相比,分类为ISF的受试者hs-CRP对数、WBC以及炎症因子仍持续升高;然而,CFS与hs-CRP对数和炎症因子之间的关联不再具有统计学意义。调整后,PCS得分也仍与各炎症指标独立相关。这些发现支持先天免疫激活在不明原因疲劳和不适中发挥作用,但并不表明免疫激活是CFS所特有的。